跳至主要内容
临床试验/JPRN-UMIN000001627
JPRN-UMIN000001627已完成未知

Efficacy of addition of HB vaccine in patients with chronic hepatitis B who are still HBeAg-positive after one year of entecavir administration: a randomized controlled trial - Entecavir plus HB vaccine combination trial

Osaka City University Graduate School of Medicine0 个研究点目标入组 50 人开始时间: 2013年3月31日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
50

研究概览

简要总结

The present study showed that HB vaccine therapy did not have anti-HBV effect for patients with entecavir poor response.

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.use of lamivudine or any other nucleos(t)ide analogues for hepatitis B 2.use of immunosuppressive or immunomodulatory drugs 3.presence of HCV infection and other likely causes of chronic liver disease 4.clinical signs of decompensated cirrhosis or liver failure 5.severe complication (poor renal, cardiac, or respiratory function) 6.women who are possibly pregnant, expectant mothers, and lactating mothers

研究者

发起方
Osaka City University Graduate School of Medicine

相似试验